Shujing Liang Jingxian Yang Yun Lin Tong Li Wenrong Zhao Jun Zhao Chunyan Dong
10.3389/fimmu.2021.682262
Front Immunol
2021 Jul 8;12:682262.
pd-1 blockade chordoma immune checkpoint inhibitor myasthenia gravis myocarditis sintilimab
CC BY
https://pubmed.ncbi.nlm.nih.gov/34305915/
Antineoplastic Agents, Immunological / adverse effects Chordoma / complications Myasthenia Gravis / complications Myocarditis / diagnosis Myocarditis / etiology
Antineoplastic Agents, Immunological / adverse effects Chordoma / complications Myasthenia Gravis / complications Myocarditis / diagnosis Myocarditis / etiology Case Reports Research Support, Non-U.S. Gov't Review Aged Antineoplastic Agents, Immunological / therapeutic use Biomarkers Chordoma / diagnosis Chordoma / drug therapy Heart Function Tests Humans Immunosuppressive Agents / therapeutic use Kidney Function Tests Liver Function Tests Magnetic Resonance Imaging Male Molecular Targeted Therapy / adverse effects Myocarditis / drug therapy Positron-Emission Tomography Programmed Cell Death 1 Receptor / antagonists & inhibitors Antineoplastic Agents, Immunological Biomarkers Immunosuppressive Agents PDCD1 protein, human Programmed Cell Death 1 Receptor
PMC8297709
34305915
Immune Myocarditis Overlapping With Myasthenia Gravis Due to Anti-PD-1 Treatment for a Chordoma Patient: A Case Report and Literature Review
2021